Wilmer Cutler Pickering Hale and Dorr and Cooley advised on Terns Pharmaceuticals, Inc. on the offering, and Davis Polk & Wardwell advised the underwriters. Terns Pharmaceuticals,...
You must be a Standard 1 Year member to access this content.
Covington & Burling and Kirkland & Ellis acted as special counsel to Eli Lilly and Company, while Davis Polk & Wardwell advised the joint book-running managers...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised the several initial purchasers on the offering. Immunocore Holdings plc (Immunocore) (Nasdaq: IMCR) announced the pricing of $350.0 million aggregate principal amount...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Immatics N.V. on the offering, and Covington & Burling advised the underwriters. Immatics N.V. (Nasdaq: IMTX) announced its $201 million SEC-registered offering...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised the representatives of the several initial purchasers on the offering. Merit Medical Systems, Inc. (Nasdaq: MMSI) (Merit) announced its $747.5 million of its...
You must be a Standard 1 Year member to access this content.
King & Spalding advised Evolent Health, Inc. on the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. Evolent Health, Inc. (NYSE:...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell represented Polaris in the offering, and Cravath Swaine & Moore advised the underwriters. Polaris Inc. (NYSE:PII) announced its debut SEC-registered offering of $500...
You must be a Standard 1 Year member to access this content.
Gide Loyrette Nouel and Cooley represented Inventiva S.A. on the offering. Davis Polk & Wardwell and Linklaters TD advised Cowen, as the sales agent. Inventiva S.A....
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault LLP and Sullivan & Cromwell LLP are advising Enbridge Inc., while Baker Botts L.L.P. and Dentons Canada LLP are advising the underwriters in the...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell represented the initial purchasers in the offering. Tetra Tech, Inc. announced its Rule 144A offering of $575 million aggregate principal amount of its 2.25%...
You must be a Standard 1 Year member to access this content.
Cooley advised Gracell Biotechnologies; and Davis Polk & Wardwell advised the placement agents on the deal. Gracell Biotechnologies Inc. (Nasdaq: GRCL) announced that it has entered into a...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Immatics N.V. in the deal. Immatics N.V. announced its $35 million private placement of ordinary shares. All of the shares were purchased...
You must be a Standard 1 Year member to access this content.
